This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kenichi Fukaya: Innovator in Hepatocyte Research
Introduction
Kenichi Fukaya is a prominent inventor based in Katsuyama, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of human-derived immortalized liver cell lines. His work is crucial for advancing therapeutic strategies for hepatic insufficiency.
Latest Patents
Kenichi Fukaya holds a patent for a "Human derived immortalized liver cell line." This invention relates to a new immortalized hepatocyte culture of human normal cell origin, preferably from human fetal sources. The immortalized hepatocyte culture is particularly useful for screening compounds or salts that may have therapeutic or preventive effects on hepatic insufficiency.
Career Highlights
Fukaya is associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in hepatocyte research. His innovative work has the potential to impact drug development and improve treatment options for liver-related diseases.
Collaborations
Kenichi Fukaya has collaborated with notable colleagues, including Masayoshi Nanba and Satoru Asahi. These partnerships enhance the research environment and foster innovation in the field of hepatocyte studies.
Conclusion
Kenichi Fukaya's contributions to the development of immortalized liver cell lines represent a significant advancement in biomedical research. His work not only aids in understanding liver diseases but also paves the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile